Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most ...
Botstein, Princeton’s Anthony B. Evnin ‘62 Professor of Genomics, Emeritus, and an emeritus professor of molecular biology ...
Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...
Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries that use these ...
"If someone wants a highly structured, low-ambiguity environment, they won't be happy at Lovable," the startup's people chief ...
At least a handful of times a year, unpredictable seizures overcome two young Sydney sisters and cut off their airways. Every ...
CRISPR is a powerful DNA-editing tool that has underpinned huge advancements in human health care in the last decade. It is a ...
Skin conditions such as psoriasis often flare up in the same spots throughout one’s life. Now scientists think they know why ...
AI is giving bad advice to flatter its users, says new study on dangers of overly agreeable chatbots
Artificial intelligence chatbots are so prone to flattering and validating their human users that they are giving bad advice ...
New study traces how a protein essential for hearing evolved from an ancient ion channel into today’s exquisitely sensitive ...
A new single-cell atlas shows how epigenetic changes reshape brain cells during aging, revealing genomic instability, ...
Researchers are building a massive genomic atlas to overcome data limitations in AI drug discovery, enabling advanced models to learn from diverse species, and accelerate therapeutic design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results